1/9/2019
Nexvax2 Therapeutic Vaccine Fast-Tracked by FDA
ImmusanT, Inc., has announced that its therapeutic vaccine candidate, Nexvax2, has been granted Fast Track designation by the U.S. Food and Drug Administration (FDA).
Continue ReadingFeatured News
Tag: Therapeutic Vaccine
Recent Posts
- AOECS 2024 Conference Recap
- Latin American Society for the Study of Celiac Disease Symposium Recap
- Celiac Disease Foundation Highlights Innovation at NASPGHAN
- New Study Highlights Increased Risks of GI Cancers and Inflammatory Diseases in Celiac Patients
Search the archive
Categories
- Advocacy News
- Celiac Disease in the News
- Clinical Trials
- Eat! Gluten-Free
- Featured
- Foundation Press
- iCureCeliac
- Marilyn’s Message
- Monthly eNewsletter
- Patient Profile Advocacy Series
- Recipes
- Research
- Research News
- Research Press
- Trending Topics
Marilyn's Message
9/26/2024
Read more2024 International Celiac Disease Symposium Recap
Last month, the Celiac Disease Foundation had the privilege of sponsoring the 2024 International Celiac Disease Symposium in Sheffield, UK. As the first patient advocate invited to chair and present on a scientific panel, CEO Marilyn Geller co-chaired the End Points in Clinical Trials session with Dr. Francisco Leon, CEO of...